We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Medlab Middle East 2024 Provides a Peek into the Laboratory of the Future

By LabMedica International staff writers
Posted on 05 Feb 2024
Print article
Image: Medlab Middle East 2024 has seen a 20% increase in exhibitors (Photo courtesy of Informa Markets)
Image: Medlab Middle East 2024 has seen a 20% increase in exhibitors (Photo courtesy of Informa Markets)

Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress organized by Informa Markets, has returned to the Dubai World Trade Centre. Now in its 23rd year, Medlab Middle East features 900 exhibitors from more than 40 countries, up 20% from last year, and is being attended by more than 30,000 attendees. As the MENA region's most prominent medical laboratory exhibition and congress, Medlab Middle East plays a crucial role in developing the value of laboratory medicine in reshaping the future of diagnostics by providing a platform for laboratory industry leaders, including manufacturers, dealers, and distributors, to share best practice, showcase innovations, collaborate and network.

Medlab Middle East 2024 is exhibiting eight specialized product categories which include disposables, healthcare/general services, imaging, infrastructure, IT, laboratory, medical equipment and pharma/nutrition. Attendees can explore the latest laboratory technologies from every corner of the globe with dedicated country pavilions from China, Taiwan, Brazil, Finland, Poland, the USA, Spain, Korea, Italy, Egypt, and the UK. A key highlight of the 2024 edition of Medlab Middle East, taking place from 5-8 February, is the newly introduced ‘NextGen Medicine Zone and Conference, which is hosted in partnership with Express Med Diagnostics and Research (Manama, Bahrain). This innovative exhibition zone showcases over 100 exhibitors and brings into focus a pioneering area in the medical laboratory field that aims to customize healthcare to individuals, using advanced technologies and new developments in medical science.

The NextGen Medicine Conference, taking place from 5 to 6 February, explores topics such as early cancer detection, precision oncology, preventative health screening, longevity, developments in cancer genetics and oncogenomics as well as updates on Middle East genome projects. The conference also explores the digitalization aspects of NextGen Medicine which includes Artificial Intelligence (AI), bioinformatics, and the cybersecurity of data. Attendees can stay up to date with the latest insights and innovations in NextGen Medicine at expert-led industry workshops running from 5-7 February. Medlab Middle East Congress, the region’s only multi-disciplinary congress, has returned for another year. Offering 12 CME-accredited live in-person conferences throughout the four-day exhibition, the congress features over 130 speakers and 150 sessions, with over 4,000 delegates expected. NextGen Medicine and Clinical Genomic Interpretation are new additions to the Medlab Middle East congress this year, with returning tracks including Laboratory Management, Lab Quality Management, Clinical Chemistry, Immunology, Hematology, Clinical Microbiology, Blood Transfusion Medicine, Histopathology, Future of Lab and Sustainability in the Lab.

Additionally, innovation takes center stage at Labpreneur, Medlab Middle East’s annual start-up competition. Held on the last day of the exhibition, Labpreneur features 10 shortlisted start-ups that have created revolutionary concepts for the medical laboratory field. The winner of the competition is set to receive complimentary stand space for Medlab Middle East 2025 along with a prestigious award. Fostering the talents of future scientists, Medlab Middle East is hosting the second edition of LabQ, an inter-college quiz competition on pathology and laboratory medicine for senior graduating college and university students majoring in medical laboratory sciences in the UAE. The Scientific Poster Competition is returning this year, with the winner receiving a research grant of a value of up to USD 3,000. Elsewhere, attendees can expand their knowledge of the medical laboratory industry at the Medlab Partners Forum, which includes a think tank session from global research firm Frost & Sullivan and an insightful presentation from The Royal College of Pathologists on ‘The Global Challenge of Antimicrobial Resistance’.

“Medlab Middle East provides a unique platform for the laboratory industry to showcase innovative products, state-of-the-art services, and cutting-edge solutions in a central global hub,” said Tom Coleman, Exhibition Director for Informa Markets. “One of the most exciting features of this year's exhibition is the NextGen Medicine Zone and Conference, which promises to be a game-changer in the field. This groundbreaking zone will bring together experts from around the world who will share the latest scientific advancements, providing a unique opportunity for industry professionals to learn and explore new possibilities.”

Related Links:
Informa Markets
Express Med Diagnostics and Research

Gold Member
Troponin T QC
Troponin T Quality Control
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
New
Orienta Tsutsugamushi Test
STANDARD Q Tsutsugamushi IgM/IgG

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
MEDLAB 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.